ONLY GROUP Type of group

11 trials

Sponsors

GLAXOSMITHKLINE RESEARCH TRIANGLE PARK,, PFIZER S.A.,, SCHERING PLOUGH RESEARCH INSTITUTE,, SOLVAY PHARMACEUTICALS,, TRANSKARYOTIC THERAPIES, INC.,

Unknown Phase

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Active, not recruitingPER-019-06

Start: 2006-08-25Target: 24Updated: 2023-09-04

Use of Idursulfase by a specific Patient: Alternative Access to Treatment among Patients with Selected MPS II who participate in the study TKT024EXT

Active, not recruitingPER-033-06

TRANSKARYOTIC THERAPIES, INC.,

Start: 2006-09-11Target: 1Updated: 2023-09-04

Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP

Active, not recruitingPER-089-06

Start: 2007-09-03Target: 20Updated: 2023-09-04

EXTEND (Eltrombopag Extended Dosing Study)

Active, not recruitingPER-084-06

GLAXOSMITHKLINE PERU S.A.,

Start: 2006-06-13Target: 10Updated: 2023-09-04

Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes

Active, not recruitingPER-110-06

TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER, INC.,

Target: 70Updated: 2023-09-04

Doxorubicin and Bortezomib in Treating Patients With Liver Cancer

Active, not recruitingPER-059-06

EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),

Updated: 2023-09-04

5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients

Active, not recruitingPER-118-06

ADVENTRIX PHARMACEUTICALS U.S.A,

Start: 2007-05-29Target: 8Updated: 2023-09-04

Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)

Active, not recruitingPER-023-07

SCHERING PLOUGH RESEARCH INSTITUTE,

Start: 2007-09-04Target: 5Updated: 2023-09-04

An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients

Active, not recruitingPER-031-07

SOLVAY PHARMACEUTICALS,

Start: 2007-10-23Target: 12Updated: 2023-09-04

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Active, not recruitingPER-005-07

GLAXOSMITHKLINE RESEARCH TRIANGLE PARK,

Start: 2008-05-23Updated: 2023-09-04

LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.

Active, not recruitingPER-040-07

PRODUCTOS ROCHE Q.F.S.A.,

Start: 2006-12-26Target: 9Updated: 2023-09-04